Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation.
Myocardial preservation by Bretschneider histidine-tryptophan-ketoglutarate (HTK) solution (Custoidol) was studied in transplanted patients. Post-operative creatine kinase (CK), CK-MB and troponin I were higher in patients with an ischemic time of >or=4 hours; however, values were within the acceptable range for clinical heart transplantation.
Minami
Kazutomo
K
Department of Thoracic Cardiovascular Surgery, Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany. kminami@hdz-hrw.de
Omoto
Tadashi
T
Böthig
Dietmar
D
Tenderich
Gero
G
Wlost
Stefan
S
Schütt
Ulrich
U
Körfer
Reiner
R
D000328:Adult; D003402:Creatine Kinase / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006321:Heart; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008353:Mannitol / Q000494:pharmacology*; D009926:Organ Preservation; D019188:Organ Preservation Solutions / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology*; D011343:Procaine / Q000494:pharmacology*; D019210:Troponin I / Q000378:metabolism*
C039984:Bretschneider cardioplegic solution; D019188:Organ Preservation Solutions; D019210:Troponin I; D008353:Mannitol; D011343:Procaine; D011189:Potassium Chloride; D003402:Creatine Kinase; D005947:Glucose